巨子生物(02367)拟折让约9.50%先旧后新配股最高净筹约22.94亿港元

智通财经2025-04-17

智通财经APP讯，巨子生物(02367)公布，于2025年4月16日(交易时段后)，该公司、补足卖方及联席账簿管理人订立配售及认购协议，据此，补足卖方已同意出售所持有的3500万股股份，每股配售价66.65港元;该公司有条件同意向补足卖方发行有关数目的新股份(相等于卖方配售项下实际配售的股份)，每股配售价66.65港元。预期概无承配人将于紧随配售及认购完成后成为该公司的主要股东。配售价每股...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2528201260?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-17 06:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2528201260","market":"hk","top_or_hot":-1,"title":"巨子生物(02367)拟折让约9.50%先旧后新配股 最高净筹约22.94亿港元","media":"智通财经","content":"<div>\n<p>智通财经APP讯，巨子生物(02367)公布，于2025年4月16日(交易时段后)，该公司、补足卖方及联席账簿管理人订立配售及认购协议，据此，补足卖方已同意出售所持有的3500万股股份，每股配售价66.65港元;该公司有条件同意向补足卖方发行有关数目的新股份(相等于卖方配售项下实际配售的股份)，每股配售价66.65港元。预期概无承配人将于紧随配售及认购完成后成为该公司的主要股东。配售价每股...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1279827.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>巨子生物(02367)拟折让约9.50%先旧后新配股 最高净筹约22.94亿港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n巨子生物(02367)拟折让约9.50%先旧后新配股 最高净筹约22.94亿港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-17 06:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1279827.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，巨子生物(02367)公布，于2025年4月16日(交易时段后)，该公司、补足卖方及联席账簿管理人订立配售及认购协议，据此，补足卖方已同意出售所持有的3500万股股份，每股配售价66.65港元;该公司有条件同意向补足卖方发行有关数目的新股份(相等于卖方配售项下实际配售的股份)，每股配售价66.65港元。预期概无承配人将于紧随配售及认购完成后成为该公司的主要股东。配售价每股...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1279827.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2488822045.USD","symbol_name":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1279827.html","article_id":"2528201260","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2528201260","pubTimestamp":1744841848,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，巨子生物 公布，于2025年4月16日，该公司、补足卖方及联席账簿管理人订立配售及认购协议，据此，补足卖方已同意出售所持有的3500万股股份，每股配售价66.65港元;该公司有条件同意向补足卖方发行有关数目的新股份，每股配售价66.65港元。配售价每股66.65港元较2025年4月16日收市价每股股份73.65港元折让约9.50%，配售及认购所得款项总额预期合共约为23.33亿港元，而配售及认购所得款项净额预期合共约为22.94亿港元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD","BK1207":"个人用品","02367":"巨子生物"},"translate_title":"Juzi Biotech (02367) plans to offer a discount of approximately 9.50%, with a maximum net raising of approximately HK $2.294 billion in top-up allotment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"智通财经APP讯，巨子生物(02367)公布，于2025年4月16日(交易时段后)，该公司、补足卖方及联席账簿管理人订立配售及认购协议，据此，补足卖方已同意出售所持有的3500万股股份，每股配售价66.65港元;该公司有条件同意向补足卖方发行有关数目的新股份(相等于卖方配售项下实际配售的股份)，每股配售价66.65港元。预期概无承配人将于紧随配售及认购完成后成为该公司的主要股东。配售价每股66.65港元较2025年4月16日收市价每股股份73.65港元折让约9.50%，配售及认购所得款项总额预期合共约为23.33亿港元，而配售及认购所得款项净额(经扣除佣金及估计开支后)预期合共约为22.94亿港元。配售及认购所得款项净额拟用于核心业务的发展及生态圈布局，包括但不限于品牌推广、市场营销、品类扩展、海外业务及研发投入;及补充流动资金及作一般企业用途。公告称，本次配售及认购募集资金到位后，将增强集团的资金实力、市场竞争力及综合实力，促进集团长远健康及可持续发展。配售及认购亦将透过吸引若干高品质机构投资者进一步丰富公司股东基础，并且通过配售进一步加强股份流动性。认购股份将根据一般授权配发及发行。据悉，补足卖方是一家根据英属维京群岛法律注册成立的有限责任公司。于本公告日期，补足卖方于581,104,935股股份中拥有权益，占公司现有已发行股本约56.10%，并是以FY Family Trust为受益人的控股工具，执行董事严建亚先生的配偶范代娣博士为委托人及受益人。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528201260","isCrawlerRequest":true}

巨子生物(02367)拟折让约9.50%先旧后新配股 最高净筹约22.94亿港元

精彩评论

巨子生物(02367)拟折让约9.50%先旧后新配股最高净筹约22.94亿港元